Two other MAs, including only three (12) and six RCTs (13), reported a preventive antidiabetic effect of GLP-1 RAs in patients with obesity and prediabetes (12, 13); however, they both failed to explain heterogeneity (12, 13). Here, GLP1R is linked to prediabetes syndrome.